Compare Stocks

Compare stocks with our powerful stock comparison tool. Analyze fundamentals, price performance, and key financial indicators to make informed investment decisions. Our tool lets you compare up to ten stocks side by side based on Performance Charts, Price & Volume, MarketRank™, Analyst Ratings, Sales & Book Value, Profitability & Earnings, Dividends, Debt, Ownership, Headlines, and more. Simply enter up to ten stock symbols (e.g., BAC, JPM, WFC, C, GS) to get started and uncover top investment opportunities.

CompanyCurrent Price50-Day Moving Average52-Week RangeMarket CapBetaAvg. VolumeToday's Volume
Artivion, Inc. stock logo
AORT
Artivion
$18.56
+0.1%
$22.35
$18.11
▼
$48.25
$904.56M1.31832,555 shs814,613 shs
Beta Bionics, Inc. stock logo
BBNX
Beta Bionics
$13.35
-6.9%
$18.17
$8.80
▼
$32.71
$779.08M3.441.17 million shs2.28 million shs
Bioventus Inc. stock logo
BVS
Bioventus
$9.95
-6.4%
$12.87
$6.47
▼
$15.89
$894.85M0.66702,283 shs571,971 shs
ClearPoint Neuro, Inc. stock logo
CLPT
ClearPoint Neuro
$7.31
-5.2%
$10.77
$7.25
▼
$19.63
$247.14M1.38714,779 shs704,764 shs
7 Energy Stocks to Buy and Hold Forever Cover

Oil still powers the global economy, but AI is reshaping the energy opportunity. Discover seven stocks spanning traditional energy, infrastructure, and next-generation power.

Get This Free Report

Compare Price Performance

Company1-Day Performance7-Day Performance30-Day Performance90-Day Performance1-Year Performance
Artivion, Inc. stock logo
AORT
Artivion
+1.24%-8.06%-16.57%-33.71%-58.68%
Beta Bionics, Inc. stock logo
BBNX
Beta Bionics
-2.65%-19.54%-14.90%-26.44%-47.14%
Bioventus Inc. stock logo
BVS
Bioventus
+0.19%-3.37%-21.28%-25.89%+51.93%
ClearPoint Neuro, Inc. stock logo
CLPT
ClearPoint Neuro
-1.91%-15.92%-15.92%-49.24%-46.08%
CompanyCurrent Price50-Day Moving Average52-Week RangeMarket CapBetaAvg. VolumeToday's Volume
Artivion, Inc. stock logo
AORT
Artivion
$18.56
+0.1%
$22.35
$18.11
▼
$48.25
$904.56M1.31832,555 shs814,613 shs
Beta Bionics, Inc. stock logo
BBNX
Beta Bionics
$13.35
-6.9%
$18.17
$8.80
▼
$32.71
$779.08M3.441.17 million shs2.28 million shs
Bioventus Inc. stock logo
BVS
Bioventus
$9.95
-6.4%
$12.87
$6.47
▼
$15.89
$894.85M0.66702,283 shs571,971 shs
ClearPoint Neuro, Inc. stock logo
CLPT
ClearPoint Neuro
$7.31
-5.2%
$10.77
$7.25
▼
$19.63
$247.14M1.38714,779 shs704,764 shs
7 Energy Stocks to Buy and Hold Forever Cover

Oil still powers the global economy, but AI is reshaping the energy opportunity. Discover seven stocks spanning traditional energy, infrastructure, and next-generation power.

Get This Free Report

Compare Price Performance

Company1-Day Performance7-Day Performance30-Day Performance90-Day Performance1-Year Performance
Artivion, Inc. stock logo
AORT
Artivion
+1.24%-8.06%-16.57%-33.71%-58.68%
Beta Bionics, Inc. stock logo
BBNX
Beta Bionics
-2.65%-19.54%-14.90%-26.44%-47.14%
Bioventus Inc. stock logo
BVS
Bioventus
+0.19%-3.37%-21.28%-25.89%+51.93%
ClearPoint Neuro, Inc. stock logo
CLPT
ClearPoint Neuro
-1.91%-15.92%-15.92%-49.24%-46.08%
CompanyConsensus Rating ScoreConsensus RatingConsensus Price Target% Upside from Current Price
Artivion, Inc. stock logo
AORT
Artivion
2.71
Moderate Buy$39.00110.19% Upside
Beta Bionics, Inc. stock logo
BBNX
Beta Bionics
2.67
Moderate Buy$23.6977.50% Upside
Bioventus Inc. stock logo
BVS
Bioventus
2.83
Moderate Buy$16.6066.92% Upside
ClearPoint Neuro, Inc. stock logo
CLPT
ClearPoint Neuro
2.33
Hold$24.33232.88% Upside

Current Analyst Ratings Breakdown

Latest CLPT, AORT, BVS, and BBNX Analyst Ratings

DateCompanyBrokerageActionRatingPrice TargetDetails
11/16/2026
Beta Bionics, Inc. stock logo
BBNX
Beta Bionics
Reiterated RatingSell (D-)
11/6/2026
Artivion, Inc. stock logo
AORT
Artivion
Lower Price TargetBuy$40.00 ➝ $30.00
11/6/2026
Artivion, Inc. stock logo
AORT
Artivion
Lower Price TargetMarket Outperform$48.00 ➝ $42.00
11/4/2026
Artivion, Inc. stock logo
AORT
Artivion
Reiterated RatingSell (D-)
11/4/2026
Bioventus Inc. stock logo
BVS
Bioventus
DowngradeBuy (B-) ➝ Hold (C+)
11/3/2026
Bioventus Inc. stock logo
BVS
Bioventus
Lower Price TargetBuy$19.00 ➝ $18.00
10/29/2026
ClearPoint Neuro, Inc. stock logo
CLPT
ClearPoint Neuro
Lower Price TargetBuy$22.00 ➝ $18.00
10/28/2026
Beta Bionics, Inc. stock logo
BBNX
Beta Bionics
Boost Price TargetHold$18.00 ➝ $21.00
10/28/2026
Beta Bionics, Inc. stock logo
BBNX
Beta Bionics
Reiterated RatingOverweight$20.00 ➝ $24.00
10/20/2026
Artivion, Inc. stock logo
AORT
Artivion
Initiated CoverageBuy$31.00
10/20/2026
Artivion, Inc. stock logo
AORT
Artivion
Initiated CoverageBuy$31.00
(Data available from 11/19/2023 forward. View 10+ years of historical ratings with our analyst ratings screener.)
CompanyAnnual RevenuePrice/SalesCashflowPrice/CashBook ValuePrice/Book
Artivion, Inc. stock logo
AORT
Artivion
$441.33M2.05$1.10 per share16.83$9.15 per share2.03
Beta Bionics, Inc. stock logo
BBNX
Beta Bionics
$100.25M7.24N/AN/A$7.38 per share1.81
Bioventus Inc. stock logo
BVS
Bioventus
$568.09M1.48$1.19 per share8.33$3.46 per share2.87
ClearPoint Neuro, Inc. stock logo
CLPT
ClearPoint Neuro
$36.97M6.34N/AN/A$0.85 per share8.60
CompanyNet IncomeEPSTrailing P/E RatioForward P/E RatioP/E GrowthNet MarginsReturn on Equity (ROE)Return on Assets (ROA)Next Earnings Date
Artivion, Inc. stock logo
AORT
Artivion
$9.77M-$0.3640.3039.48N/A-3.65%5.12%2.36%N/A
Beta Bionics, Inc. stock logo
BBNX
Beta Bionics
-$73.20M-$1.84N/AN/AN/A-65.31%-27.33%-24.28%N/A
Bioventus Inc. stock logo
BVS
Bioventus
$22.73M$0.8013.6111.301.369.78%26.31%10.13%N/A
ClearPoint Neuro, Inc. stock logo
CLPT
ClearPoint Neuro
-$25.54M-$1.21N/AN/AN/A-79.43%-170.24%-37.00%N/A

Latest CLPT, AORT, BVS, and BBNX Earnings

DateQuarterCompanyConsensus EstimateReported EPSBeat/MissGap EPSRevenue EstimateActual RevenueDetails
11/5/2026Q3 2026
Artivion, Inc. stock logo
AORT
Artivion
-$0.0613$0.08+$0.1413-$0.16$120.98 million$123.79 million
11/2/2026Q3 2026
Bioventus Inc. stock logo
BVS
Bioventus
$0.17$0.17N/A$0.08N/A$142.44 million
10/28/2026Q3 2026
ClearPoint Neuro, Inc. stock logo
CLPT
ClearPoint Neuro
-$0.3150-$0.24+$0.0750-$0.24$12.30 million$12.08 million
10/27/2026Q3 2026
Beta Bionics, Inc. stock logo
BBNX
Beta Bionics
-$0.53-$0.52+$0.01-$0.52N/A$35.51 million
CompanyAnnual PayoutDividend Yield5-Year Annualized Dividend GrowthPayout RatioYears of Consecutive Growth
Artivion, Inc. stock logo
AORT
Artivion
N/AN/AN/AN/AN/A
Beta Bionics, Inc. stock logo
BBNX
Beta Bionics
N/AN/AN/AN/AN/A
Bioventus Inc. stock logo
BVS
Bioventus
N/AN/AN/AN/AN/A
ClearPoint Neuro, Inc. stock logo
CLPT
ClearPoint Neuro
N/AN/AN/AN/AN/A
CompanyDebt-to-Equity RatioCurrent RatioQuick Ratio
Artivion, Inc. stock logo
AORT
Artivion
0.82
4.42
3.02
Beta Bionics, Inc. stock logo
BBNX
Beta Bionics
N/A
8.92
8.22
Bioventus Inc. stock logo
BVS
Bioventus
0.72
1.68
1.16
ClearPoint Neuro, Inc. stock logo
CLPT
ClearPoint Neuro
1.86
6.76
5.77

Institutional Ownership

CompanyInstitutional Ownership
Artivion, Inc. stock logo
AORT
Artivion
86.37%
Beta Bionics, Inc. stock logo
BBNX
Beta Bionics
N/A
Bioventus Inc. stock logo
BVS
Bioventus
62.94%
ClearPoint Neuro, Inc. stock logo
CLPT
ClearPoint Neuro
30.08%

Insider Ownership

CompanyInsider Ownership
Artivion, Inc. stock logo
AORT
Artivion
6.30%
Beta Bionics, Inc. stock logo
BBNX
Beta Bionics
5.30%
Bioventus Inc. stock logo
BVS
Bioventus
33.50%
ClearPoint Neuro, Inc. stock logo
CLPT
ClearPoint Neuro
6.94%
CompanyEmployeesShares OutstandingFree FloatOptionable
Artivion, Inc. stock logo
AORT
Artivion
1,80048.79 million45.72 millionOptionable
Beta Bionics, Inc. stock logo
BBNX
Beta Bionics
42354.37 million51.49 millionOptionable
Bioventus Inc. stock logo
BVS
Bioventus
96084.26 million56.03 millionOptionable
ClearPoint Neuro, Inc. stock logo
CLPT
ClearPoint Neuro
17232.05 million29.83 millionOptionable

Recent News About These Companies

ClearPoint Neuro stock: ATM offering cap raised to $150 million
ClearPoint Neuro (CLPT) AI Stock Analysis
ClearPoint Neuro: Momentum Building Across The Business
Clearpoint Neuro Inc. (CLPT) PT Lowered to $18 at Stifel
ClearPoint Neuro (CLPT) Q3 2026 Earnings Call Transcript

New MarketBeat Followers Over Time

Media Sentiment Over Time

Artivion stock logo

Artivion NYSE:AORT

$18.56 +0.02 (+0.08%)
Closing price 03:59 PM Eastern
Extended Trading
$19.05 +0.49 (+2.66%)
As of 07:30 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Massive. Learn more.

Artivion, Inc. manufactures, processes, and distributes medical devices and implantable human tissues worldwide. The company provides BioGlue, a polymer consisting of bovine blood protein and an agent for cross-linking proteins for cardiac, vascular, neurologic, and pulmonary procedures; cardiac preservation services; PhotoFix, a bovine pericardial patch; and aortic arch stent grafts including E-vita Open Plus and E-vita Open Neo. It offers E-xtra design engineering systems for the treatment of aortic vascular diseases; E-nside, an off-the-shelf stent graft for the treatment of thoraco-abdominal disease; E-vita THORACIC 3G for the endovascular treatment of thoracic aortic aneurysms; E-ventus BX, a balloon-expandable peripheral stent graft for the endovascular treatment of renal and pelvic arteries; E-liac to treat aneurysmal iliac arteries, and aneurysmal iliac side branches; and E-tegra, a stent graft system for the treatment of infrarenal abdominal aortic aneurysms. In addition, the company offers synthetic vascular grafts for use in open aortic and peripheral vascular surgical procedures; PerClot, an absorbable powdered hemostat for use in surgical procedures; cardiac laser therapy products for angina treatment; CryoVein femoral vein and CryoArtery femoral artery vascular preservation services; On-X prosthetic aortic and mitral heart valves and the On-X ascending aortic prosthesis; CarbonAid CO2 diffusion catheters and Chord-X ePTFE sutures for mitral chordal replacement; and ascyrus medical dissection stents, as well as pyrolytic carbon coating services to medical device manufacturers. It serves physicians, hospitals, and other healthcare facilities, as well as cardiac, vascular, thoracic, and general surgeons. The company was formerly known as CryoLife, Inc. and changed its name to Artivion, Inc. in January 2022. Artivion, Inc. was incorporated in 1984 and is headquartered in Kennesaw, Georgia.

Beta Bionics stock logo

Beta Bionics NASDAQ:BBNX

$13.35 -0.98 (-6.85%)
Closing price 03:59 PM Eastern
Extended Trading
$13.09 -0.26 (-1.91%)
As of 07:56 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Massive. Learn more.

Beta Bionics, Inc. is a commercial-stage medical device company. It engages in the design, development, and commercialization of solutions for insulin-requiring people with diabetes. The company was founded by Edward R. Damiano on October 21, 2015 and is headquartered in Irvine, CA.

Bioventus stock logo

Bioventus NASDAQ:BVS

$9.94 -0.68 (-6.36%)
Closing price 03:59 PM Eastern
Extended Trading
$9.94 -0.01 (-0.09%)
As of 07:30 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Massive. Learn more.

Bioventus Inc. a medical device company, focuses on developing and commercializing clinically treatments that engage and enhance the body's natural healing process in the United States and internationally. The company's portfolio of products includes pain treatments, which comprise non-surgical joint pain injection therapies, as well as peripheral nerve stimulation products. Its surgical solutions include bone graft substitutes to fuse and grow bones, enhance results following spinal and other orthopedic surgeries; and ultrasonic medical devices for the use in precise bone sculpting, remove tumors, and tissue debridement. The company's restorative therapies comprise an ultrasonic bone healing system for fracture care; skin allografts; and products that are used to support healing of chronic wounds, as well as advanced rehabilitation devices designed to help patients regain leg or hand function. It serves physicians spanning the orthopedic continuum, including sports medicine, total joint reconstruction, hand and upper extremities, foot and ankle, podiatric surgery, trauma, spine, and neurosurgery in the physician's office or clinic, ambulatory surgical centers, or in the hospital setting. The company was founded in 2011 and is headquartered in Durham, North Carolina.

ClearPoint Neuro stock logo

ClearPoint Neuro NASDAQ:CLPT

$7.31 -0.40 (-5.19%)
Closing price 04:00 PM Eastern
Extended Trading
$7.32 +0.01 (+0.07%)
As of 07:30 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Massive. Learn more.

ClearPoint Neuro, Inc. operates as a medical device company primarily in the United States. It develops and commercializes platforms for performing minimally invasive surgical procedures in the brain under magnetic resonance imaging guided interventions. The company offers ClearPoint system, an integrated system for the insertion of deep brain stimulation electrodes, biopsy needles, and laser catheters, as well as the infusion of pharmaceuticals into the brain. It has license and collaboration agreement with Clinical Laserthermia Systems AB; license and research agreement with Koninklijke Philips N.V., UCB Biopharma SRL, and University of California and San Francisco; and development and license agreement with NE Scientific, LLC. The company was formerly known as MRI Interventions, Inc. and changed its name to ClearPoint Neuro, Inc. in February 2020. ClearPoint Neuro, Inc. was incorporated in 1998 and is headquartered in Solana Beach, California.